6Murry C E , Jennings R B , Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium[ J]. Circulation, 1986, 74(5) : 1124 -1136.
7Tong H , Imahashi K, Steenbergen C , et al . Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective [ J ]. Circ Res, 2002, 90(4) : 377 -379.
8Gross E R, Hsu A K, Gross G J. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts[J]. Circ Res, 2004, 94(7): 960 -966.
9JuhaszovaM, Zorov D B, Kim S H, et al. Glycogen synthase kinase-3betamediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore [ J]. J Clin Invest, 2004,113 (11): 1535 -1549.
10Bullard A J,Govewalla P,Yellon D M. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo [ J ]. Basic Res Cardiol, 2005, 100 (5) : 397 - 403.
3Elahi MM, Kong YX, Matata BM. Oxidative stress as a mediator of cardio-vascular disease[J]. Oxid Med Cell Longev,2009 ;2 (5) :259-69.
4Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury[J ]. Physiol Rev, 2008,88 (2) :581-609.
5Lochner A, Marais E, Genade S. Protection of the ischaemie heart: investigations into the phenomenon of ischaemic preconditioning [J]. Cardiovasc J Afr, 2009,20( 1 ) :43-51.
